BioLamina
Anders Lindblad is an experienced professional in strategic development and operations within the pharmaceutical and medical device industries. Currently serving as VP of Strategic Development and previously as COO and Interim CEO at BioLamina since April 2018, Anders has a history of leadership roles that emphasize quality assurance, quality management, and project management. Prior experience includes consultancy at Alqa Consulting, COO at Cadila Pharmaceuticals Sweden AB, and Quality Manager at Anocca, where significant contributions included establishing GMP-compliant quality systems and operational efficiency. Anders has also managed clean room facilities and quality systems in various organizations, showcasing a strong background in production and logistics. Educational credentials include a Master of Science in Industrial Engineering and Management from KTH Royal Institute of Technology.
BioLamina
1 followers
BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells.